Public Health
Is precision public health the future — or a contradiction?
21 Jan, 2022 | 09:31h | UTCIs precision public health the future — or a contradiction? – Nature
Cluster Randomized Trial: A multifactorial falls prevention program in UK care homes reduced fall rates among older people and was cost effective.
21 Jan, 2022 | 09:21h | UTCNews Release: Falls in care homes can be significantly reduced with intervention, says new study – University of Nottingham
Commentary on Twitter
NEW RESEARCH: A falls prevention programme for older people in care homes, co-designed with care home staff & residents, that involved awareness raising, education, screening, decision & implementation support was associated with a reduction in falls rate https://t.co/wupI0LeAxj
— The BMJ (@bmj_latest) December 11, 2021
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
20 Jan, 2022 | 09:17h | UTCGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis – The Lancet
Editorial: Antimicrobial resistance: time to repurpose the Global Fund – The Lancet
Commentary: Antimicrobial resistance now a leading cause of death worldwide, study finds – The Guardian
Commentary on Twitter
NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS pic.twitter.com/aWLhmdirJ8
— The Lancet (@TheLancet) January 20, 2022
1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests.
20 Jan, 2022 | 09:13h | UTCNews Release: The Lancet Planetary Health: 1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests
Related Studies:
Commentary on Twitter (thread – click for more)
NEW—Approx. 86% of people living in urban areas exposed to unhealthy particulate matter levels, leading to 1.8 million excess deaths in 2019: modelling study in @TheLancetPlanet. #AirPollutionhttps://t.co/kw34ANZ4ph
Thread 🧵 pic.twitter.com/QiRXU4QVHP
— The Lancet (@TheLancet) January 6, 2022
Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study.
18 Jan, 2022 | 09:27h | UTC
Grand Challenges in global eye health: a global prioritization process using Delphi method.
18 Jan, 2022 | 09:15h | UTCRelated podcast: Author interview
Commentary on Twitter
Roughly 2.2 billion people have vision impairment—yet 50% of sight loss is preventable.
In @LancetLongevity, Jacqueline Ramke & colleagues identify the key issues that must be addressed to improve global #EyeHealth in the context of an ageing population.https://t.co/banTov24VX pic.twitter.com/tLSZaUYXhw
— The Lancet (@TheLancet) January 6, 2022
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
13 Jan, 2022 | 08:42h | UTCInvited Commentary: The true global disease burden of mental illness: still elusive – The Lancet Psychiatry (free registration required)
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.
11 Jan, 2022 | 02:38h | UTCNews Release: Global dementia cases set to triple by 2050 unless countries address risk factors – The Lancet
Commentaries:
Forecasting the prevalence of dementia – The Lancet Public Health
Dementia cases expected to almost triple across the world by 2050 – BBC
Number of adults with dementia to exceed 150m by 2050, study finds – The Guardian
Commentary on Twitter (thread – click for more)
🆕✨First #GBDstudy forecasts global #dementia cases set to triple by 2050 (up from 57m in 2019 to expected 153m people) unless countries address risk factors: #smoking, #obesity, #HighBloodSugar, & low #education🧵👇
Published in @TheLancet @TheLancetPHhttps://t.co/GccTPRroEV
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) January 7, 2022
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
11 Jan, 2022 | 02:30h | UTC
New AAP Guidance recommends routine HIV screening to all youth 15 years or older.
8 Jan, 2022 | 23:13h | UTCCommentary: Pediatricians Can Play Key Role in HIV Testing, Prophylaxis – HealthDay
RCT: Low-cost, easy to take antiretroviral treatment based on Dolutegravir as first- or second-Line therapy found to be non-inferior to standard care for treating HIV-1 infection in children.
8 Jan, 2022 | 23:07h | UTCDolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Easy-to-take medicine better at suppressing HIV in children – University College London
Commentaries on Twitter
Dolutegravir-based antiretroviral therapy was compared with standard care in children and adolescents starting first- or second-line therapy for HIV type 1 infection. Dolutegravir-based ART was superior to standard-care ART. https://t.co/PP0XaEVswO pic.twitter.com/pQvhjdXcUk
— NEJM (@NEJM) December 29, 2021
Visual Abstract: Dolutegravir as First- or Second-Line HIV Treatment in Children https://t.co/2RIg9uH2V1 pic.twitter.com/mDr1Z6l6CJ
— NEJM (@NEJM) January 4, 2022
FDA approves first injectable treatment for HIV pre-exposure prevention.
8 Jan, 2022 | 23:04h | UTCCommentaries:
NIH celebrates FDA approval of long-acting injectable drug for HIV prevention – NIH News Releases
A new injection to prevent HIV, rather than pills, is a game-changer, scientists say – NPR
Related:
CDC Guidance: Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents
USPSTF Statement: Preexposure Prophylaxis for the Prevention of HIV Infection
British Guidelines on the Use of HIV Pre–exposure Prophylaxis (PrEP) (several guidelines on the subject)
New Protocol for HIV Prevention Drug Reduces The Number Of Pills Required
Abortion safety and use with normally prescribed Mifepristone in Canada.
16 Dec, 2021 | 08:51h | UTCNews Release: Prescribing the abortion pill without restrictions is safe and effective, study finds – University of British Columbia
Opinion: Decision makers need constantly updated evidence synthesis.
16 Dec, 2021 | 08:39h | UTCDecision makers need constantly updated evidence synthesis – Nature
Recommendations for equitable COVID-19 pandemic recovery in Canada.
14 Dec, 2021 | 09:47h | UTCNews Release: Equitable COVID-19 pandemic recovery in Canada: New guideline – Canadian Medical Association Journal
Editorial: Build back more equitably
WHO Reports | More than half a billion people pushed or pushed further into extreme poverty due to health care costs.
14 Dec, 2021 | 08:55h | UTCReport 1: Tracking Universal Health Coverage: 2021 Global monitoring report – World Health Organization
Report 2: Global monitoring report on financial protection in health 2021 – World Health Organization
WHO Report | Saving lives, spending less: the case for investing in noncommunicable diseases.
14 Dec, 2021 | 08:53h | UTC
Commentary on Twitter
🆕 WHO report shows that investing only 1⃣ USD per person per year in the prevention and control of noncommunicable diseases could save almost 7⃣ million lives 🌍 by 2030. Let's #BeatNCDs!https://t.co/KP71n5M1cY pic.twitter.com/kviaoWc2J5
— World Health Organization (WHO) (@WHO) December 13, 2021
Perspective: Alcohol-related harm is a public health issue, not a lifestyle choice.
14 Dec, 2021 | 08:41h | UTCAlcohol-related harm is a public health issue, not a lifestyle choice – Health Policy Watch
Related:
COVID-19 pandemic and alcohol consumption: Impacts and interconnections – Toxicology Reports
National, Regional, and Global Burdens of Disease Attributable to Alcohol Use
Study: Alcohol Use and Burden for 195 Countries and Territories
Study: The Global Burden of Disease Attributable to Alcohol and Drug Use
Study: Global Alcohol Exposure Between 1990 and 2017 and Forecasts Until 2030
Analysis: Prioritizing Action on Alcohol for Health and Development
Research: Contribution of alcohol use disorders to the burden of dementia
Colorectal cancer incidence, mortality, tumor characteristics, and treatment before and after the introduction of the fecal immunochemical testing-based screening program in the Netherlands: a population-based study.
13 Dec, 2021 | 08:50h | UTCColorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
New research – Breekveldt et al – #Colorectalcancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the FIT-based #screening programme in the #Netherlands: a population-based studyhttps://t.co/nW9SVAhRxE#GITwitter #crcsm pic.twitter.com/GGRF9Az0tg
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) November 23, 2021
Infodemics: a new challenge for public health.
10 Dec, 2021 | 10:18h | UTCInfodemics: A new challenge for public health – Cell
See also:
What is an infodemic and how can we prevent it?
Commentary on Twitter
What pandemics and infodemics don’t have in common could help us learn how to fight them, experts suggest in a new @CellCellPress Commentary. Read more here: https://t.co/15nVCiebLI@Walter4C pic.twitter.com/7viNB9yRvR
— Cell Press (@CellPressNews) December 9, 2021
New Zealand to ban smoking for next generation in bid to outlaw habit by 2025 – “New legislation means the legal smoking age will increase every year, to create a smoke-free generation of New Zealanders”.
9 Dec, 2021 | 10:12h | UTCNew Zealand to ban smoking for next generation in bid to outlaw habit by 2025 – The Guardian
Systematic Review: Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer.
9 Dec, 2021 | 10:08h | UTC
Commentary on Twitter (thread – click for more)
Our comprehensive #systematicreview for the #ECIBC on intervals (every 1, 2, 3 years) of #breastcancer #screening is available.
We included RCT, observational, and mathematical modeling studies to assess benefits and harms and applied the #GRADE approachhttps://t.co/IfplsWfKuA pic.twitter.com/7niEbnaWKR— Carlos Canelo-Aybar (@ccaneloa) November 27, 2021
A qualitative study identified a wide variation of expected impacts of the 626 low-value services spotted by the US Choosing Wisely recommendations.
7 Dec, 2021 | 08:39h | UTCLongitudinal Content Analysis of the Characteristics and Expected Impact of Low-Value Services Identified in US Choosing Wisely Recommendations – JAMA Internal Medicine (free for a limited period)
Editorial: The Next Frontier of Less Is More—From Description to Implementation – JAMA Internal Medicine (free for a limited period)
See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
5 Dec, 2021 | 23:09h | UTCInvited Commentary: Burden of cancer in adolescents and young adults – The Lancet Oncology
Review: Interventions to optimize antimicrobial stewardship.
3 Dec, 2021 | 10:11h | UTC